Crossmark

Radiomics using contrast-enhanced T1-weighted imaging and clinical features for predicting response to EGFR-TKIs in EGFR-mutated non-small cell lung cancer patients with brain metastases

Crossref DOI link: https://doi.org/10.1186/s12880-026-02429-6

Published Online: 2026-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sui, Lian-Yu

Zhang, Tian-Ye

Cheng, Cheng

Xing, Li-Hong

Meng, Huan

Liu, Chong

Wang, Qi

Wang, Jia-Ning

Zhang, Tian-Shuo

Liu, Kun

Yin, Xiao-Ping
Funding

Funding for this research was provided by:

Hebei University Graduate Student Innovation Funding Project (CXZZBS2025028)
License Information

Text and Data Mining valid from 2026-06-16

Accepted Manuscript valid from 2026-06-16
More Information

Article History

Received: 5 January 2026

Accepted: 8 May 2026

First Online: 16 June 2026

Declarations

:

: This retrospective study was approved by the institutional review board (“Ethics committee of the Affiliated Hospital of Hebei University”, Dongfeng Road, No. 212, Lianchi District, Baoding 071000, China, Number HDFYLL-KY-2024-037; date of approval 02/28/2024), was conducted in accordance with the Declaration of Helsinki. Informed consent was waived for all patients due to the retrospective nature of this study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below